Hi-Tech Pharmacal Co.
369 Bayview Avenue
Amityville
New York
11701
United States
Tel: 516-789-8228
Fax: 516-789-8429
145 articles about Hi-Tech Pharmacal Co.
-
Hi-Tech Pharmacal Acquires Rights to Branded Products to be Promoted by Their ECR Pharmaceuticals Subsidiary
6/28/2011
-
Hi-Tech Pharmacal Receives Final Approval for Levofloxacin Oral Solution
6/21/2011
-
Hi-Tech Pharmacal Divests its Midlothian Laboratories Division in Exchange for Cash Payment
5/11/2011
-
Hi-Tech Pharmacall Receives Tentative Approval for Brimonidine Tartrate with Timolol Maleate Ophthalmic Solution
4/8/2011
-
Hi-Tech Pharmacal Receives Final Approval for Ranitidine Syrup
3/22/2011
-
Hi-Tech Pharmacal to Release Third Quarter Earnings and Hold Conference Call on March 10, 2011
3/4/2011
-
FDA Action Affects Products Marketed by Hi-Tech Pharmacal’s ECR Pharmaceuticals Subsidiary
3/3/2011
-
Hi-Tech Pharmacal to Present at the 2011 RBC Capital Markets' Healthcare Conference
3/2/2011
-
Elite Pharmaceuticals, Inc. and Hi-Tech Pharmacal Sign a Development and Supply Agreement for a Generic Intermediate of a Prescription Product
1/10/2011
-
Hi-Tech Pharmacal Reports Sales of $44.9 Million and EPS of $0.76 for the Second Fiscal Quarter Ended October 31, 2010
12/9/2010
-
Hi-Tech Pharmacal to Release Second Quarter Earnings and Hold Conference Call on December 9, 2010
12/3/2010
-
Hi-Tech Pharmacal Will Market Generic Buprenorphine HCl Sublingual Tablets
9/27/2010
-
Hi-Tech Pharmacal to Present at the UBS Global Life Sciences Conference
9/21/2010
-
Hi-Tech Pharmacal Reports Sales of $40.4 Million and EPS of $0.67 for the Quarter Ended July 31, 2010
9/8/2010
-
Hi-Tech Pharmacal to Release First Quarter Earnings and Hold Conference Call on September 8, 2010
8/31/2010
-
Hi-Tech Pharmacal to Present at the Bank of America 2010 Specialty Pharmaceuticals Conference
8/11/2010
-
Hi-Tech Pharmacal Reports 6% Increase in Sales and 11% Increase in EPS for the Fourth Fiscal Quarter 2010 and a 51% Increase in Sales and an 198% Increase in EPS for Fiscal 2010
7/13/2010
-
Hi-Tech Pharmacal to Release Fourth Quarter Earnings and Hold Conference Call on July 13, 2010
7/8/2010
-
Hi-Tech Pharmacal Suspends Sales Of Certain Products, Gets Warning Letter From FDA
7/6/2010
-
Hi-Tech Pharmacal Announces the Hiring of Kamel Egbaria, Ph.D. as Chief Scientific Officer
4/28/2010